Study: NCT03441984

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A
Description: TRIUMEQ (Adult) administered as a, single dose, fixed dose combination (FDC) tablet - DTG 50 mg/ABC 600 mg/3TC 300 mg as 1 conventional tablet, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A
Description: TRIUMEQ (Adult) administered as a, single dose, fixed dose combination (FDC) tablet - DTG 50 mg/ABC 600 mg/3TC 300 mg as 1 conventional tablet, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A
Description: TRIUMEQ (Adult) administered as a, single dose, fixed dose combination (FDC) tablet - DTG 50 mg/ABC 600 mg/3TC 300 mg as 1 conventional tablet, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A
Description: TRIUMEQ (Adult) administered as a, single dose, fixed dose combination (FDC) tablet - DTG 50 mg/ABC 600 mg/3TC 300 mg as 1 conventional tablet, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A
Description: TRIUMEQ (Adult) administered as a, single dose, fixed dose combination (FDC) tablet - DTG 50 mg/ABC 600 mg/3TC 300 mg as 1 conventional tablet, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment A
Description: TRIUMEQ (Adult) administered as a, single dose, fixed dose combination (FDC) tablet - DTG 50 mg/ABC 600 mg/3TC 300 mg as 1 conventional tablet, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/ 3TC 30 mg, orally as 10 dispersible tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/ 3TC 30 mg, orally as 10 dispersible tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/ 3TC 30 mg, orally as 10 dispersible tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/ 3TC 30 mg, orally as 10 dispersible tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/ 3TC 30 mg, orally as 10 dispersible tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment B
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/ 3TC 30 mg, orally as 10 dispersible tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/3TC 30 mg, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/3TC 30 mg, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/3TC 30 mg, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/3TC 30 mg, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/3TC 30 mg, orally as direct-to-mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment C
Description: TRIUMEQ (Pediatric) administered as a, single dose, FDC tablet - DTG 5 mg/ABC 60 mg/3TC 30 mg, orally as direct-to-mouth.